- Home
- SQNS vs ADAG Comparison
SQNS vs ADAG Comparison
Compare SQNS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- ADAG
- Stock Information
- Founded
- SQNS 2003
- ADAG 2011
- Country
- SQNS France
- ADAG China
- Employees
- SQNS N/A
- ADAG N/A
- Industry
- SQNS Semiconductors
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- ADAG Health Care
- Exchange
- SQNS Nasdaq
- ADAG Nasdaq
- Market Cap
- SQNS 46.5M
- ADAG 91.4M
- IPO Year
- SQNS 2011
- ADAG 2021
- Fundamental
- Price
- SQNS $4.52
- ADAG $1.92
- Analyst Decision
- SQNS Strong Buy
- ADAG Strong Buy
- Analyst Count
- SQNS 1
- ADAG 1
- Target Price
- SQNS $7.50
- ADAG $8.00
- AVG Volume (30 Days)
- SQNS 9.6M
- ADAG 51.2K
- Earning Date
- SQNS 08-22-2025
- ADAG 07-24-2025
- Dividend Yield
- SQNS N/A
- ADAG N/A
- EPS Growth
- SQNS N/A
- ADAG N/A
- EPS
- SQNS 2.16
- ADAG N/A
- Revenue
- SQNS $38,858,000.00
- ADAG $103,204.00
- Revenue This Year
- SQNS N/A
- ADAG $6,488.89
- Revenue Next Year
- SQNS $93.87
- ADAG $57.50
- P/E Ratio
- SQNS $1.81
- ADAG N/A
- Revenue Growth
- SQNS 40.06
- ADAG N/A
- 52 Week Low
- SQNS $0.95
- ADAG $1.33
- 52 Week High
- SQNS $5.50
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- SQNS 87.95
- ADAG 56.78
- Support Level
- SQNS $1.34
- ADAG $1.74
- Resistance Level
- SQNS $2.68
- ADAG $1.98
- Average True Range (ATR)
- SQNS 0.52
- ADAG 0.12
- MACD
- SQNS 0.29
- ADAG -0.00
- Stochastic Oscillator
- SQNS 76.77
- ADAG 72.22
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.